Embed Size (px)
DESCRIPTION
Join Tom Jenkins, author, visionary, and Chief Strategy Officer of OpenText, as he takes his latest book, Managing Content in the Cloud, on the road. In this presentation, Tom discusses how emerging Internet technologies have enabled people to find content, collaborate, and communicate faster than they could using other services or portal sites. When used securely inside the enterprise, these new tools give us the ability to collect and tap into this knowledge for tremendous productivity gains.
Citation preview
Rev 2.0 01102010
Managing Content in the Cloud for An Organization
Tom Jenkins
Executive Chairman & Chief Strategy Officer
Copyright © Open Text Corporation. All rights reserved.
China missed the Industrial Revolution
It would not be wise to miss the Information Revolution – any part of it!
Why Information Technology Matters
Why Managing Content in the Cloud Matters
Permission: Balancing Access with Security
4
Slide 5
Agenda
My Background The Impact of the Cloud Managing Content in the Cloud The Future of the Cloud
Slide 6
Agenda
My Background The Impact of the Cloud Managing Content in the Cloud The Future of the Cloud
OpenText: The Original “Google”
Jerry Yang CEO of Yahoo and Tom Jenkins CEO of OpenText launch in 1995.
OpenText provided the web search for MSN, MCI, Yahoo, IBM, etc.
OpenText Index was one of the most used web pages in early 90s.
OpenText moved into corporate search.
Today it is a billion dollar company.
Copyright © Open Text Corporation 2008 - 2009. All rights reserved.
Slide 8
With Significant Global Reach
1 in 3 global Internet users view content enabled by OpenText technology.
Slide 9
Agenda
My Background
The Impact of the Cloud Managing Content in the Cloud The Future of the Cloud
The World According to Friedman:
Hot, Flat, and Crowded
Copyright © 2009 Open Text Corporation. All rights reserved.
Slide 10
If you don’t adapt, adopt, and lead, you are…
Copyright © 2009 Open Text Corporation. All rights reserved.
Slide 11
Source: Citi Investment Research and Analysis
Cloud Computing
Content
Disruptive Emerging Maturing Saturation Decline
Surface Computing
BusinessIntelligence
ProductLifecycleManagement
CustomerRelationship
Management
SupplyChain
Management
Desktop OperatingSystem
Mainframe Software
Database
Mobile
Social Networking
A Wave of Major IT Innovations Coming Now
Copyright © Open Text Corporation. All rights reserved. 13
Evolution of Internet Nomenclature
The Future of Content: Rich Mobile Social
New Devices New Apps New Interactions New Content to Manage
15
Yet , access to Facebook, Twitter,
and YouTube is
barred in 45% of organizations
$500K prizes $3 Billion
discoveries
Key Economic Challenge
Slide 19
ValueLiability
Slide 20
Agenda
My Background The Impact of the Cloud
Managing Content in the Cloud The Future of the Cloud
The Original Books on the ECM Industry
Available online at www.opentext.com
Managing Content in the Cloud
Managing Content in the Cloud App for iPad
available on itunes. Search: Cloud App
The Business Need
Content Growth
Information Governance
Social Media and Collaboration
Social Workplace/Social Marketplace
A Secure Social Network for G20
Delivered in the Cloud
“Facebook/YouTube/Wiki/Google”
Mobile With The Same Interface
Digital Media
Content Type by Bandwidth Consumption
Copyright © 2009 Open Text Corporation. All rights reserved.
Slide 37
Digital Natives Are Different
Creativity +
Memory -
Immersive and Digital Rights Tether
Learning Delivery Is Changing
Enterprise Applications
41
ECM Adoption Stages
I Single Application
Department
IVSingle Application
VMultiDepartment
VIExtranet
III Multi Application
Enterprise Marketplace
VIIMarketplace
Number of Applications
~ 20
~ 10
~ 3
2
1
Number Of Users
<1,000 ~ 2,000 ~ 5,000 ~ 20,000 ~ 100,000
II Multi Department
Named User
GuestSame Application
Standard
Enterprise Adoption Challenges
EngagementEngagement LifecycleLifecycle TransactionTransaction
A Complete ECM Suite
Document Management
Enterprise Archiving
Rights Management
Records Management
Capture and Imaging
OCR/ICR and Classification
Business Process Management
Document Output Management
Slide 43
Social Media/Collaboration
Web Experience Management
Digital Asset Management
Customer Communication Management
Enterprise LibraryEnterprise Library
Enterprise Process ServicesEnterprise Process Services
User Experience ServicesUser Experience Services
Desktop Web Portal Mobile
Enterprise Content
Human Resources Accounting Marketing Legal Call Center
PersonnelManagement
AccountsPayable
Corporate Web Site
ContractManagement
Case Management
The OpenText ECM Suite
Enterprise Value: Content Flow – Write Once – Use Many Times
Corporate
Slide 47
Organize Content to Support the Value Chain
Ordering Manufacturing DistributionMarketing/Sales Services
Primary Activities
SAP Integration: Structured Content (ERP)with Unstructured Content (ECM)
SAP Integrations with OpenText
SAPRUNSOPEN TEXT
«SAP runs WCM» «SAP runs DAM» «SAP runs AP»
«SAP runs Document Access»
«SAP runs ContractMgmt»
«SAP runs SAP Archiving»
«SAP runs PDMS»
«SAP runs Email Archiving»
«SAP runs EIM»
«SAP runs CIM»
Cloud Computing
The Cloud
Content in the Cloud
Social Networks
Wiki
Podcasts
Blogs
Folksonomies
Communities
Videocasting
RSS
Social Bookmarking
Aggregators
Widgets
AJAX
53
New Content Types with the Cloud
54
Mobile Rich Media Drives New Content Types
Mobility
57
Social Documents Processes Web Apps
Many Smartphones
Many Tablets
Example: Mobilizing Workflow
Slide 60
Agenda
My Background The Impact of the Cloud Managing Content in the Cloud
The Future of the Cloud
ECM and the Future
Web 3.0: The Semantic Web
The three main IT innovations will drive semantic:
The GPS in mobile provides physical context
The social networks provide people context
The cloud repositories provide content context
Cloud Content: Rich Mobile Social Personal
New Devices New Apps New Interactions New Content to Manage
64
How To Get There – $Billions in Research
• $1 Billion+ for Content & Application Research in past and next 5 years
• 2,000 Developers on average over the next five years
• Inventing the Future of ECM in the Content Decade
Slide 65
How To Get There - $Billions in Acquisitions
$1 Billion+ invested in past 5 years
Integrated: Technology Service & support Solutions knowledge Geographic reach
Strategy will continue over the next 5 years
Slide 66
Example: Adding A Semantic Engine
67
Mining an Article
68
FDA says drug stents have small blood clot risk Last Update: 11:15 AM ET May 5, 2008
WASHINGTON (MarketWatch) -- The Food and Drug Administration said Tuesday that drug-coated stents made by Johnson & Johnson (JNJ) and Boston Scientific Corp. (BSX) carry a significant risk of blood clots that appears to emerge a year or later after the stents are placed.
The agency said the risk applies to the drug stents currently on the U.S. market made by Johnson & Johnson and Boston Scientific when compared with older so-called bare metal stents.
The FDA said it was not yet clear if the drug stents carried an increased risk of heart attacks or death compared with the bare metal stents.
Key Words and Key Phrases
69
FDA says drug stents have small blood clot risk Last Update: 11:15 AM ET May 5, 2008
WASHINGTON (MarketWatch) -- The Food and Drug Administration said Tuesday that drug-coated stents made by Johnson & Johnson (JNJ) and Boston Scientific Corp. (BSX) carry a significant risk of blood clots that appears to emerge a year or later after the stents are placed.
The agency said the risk applies to the drug stents currently on the U.S. market made by Johnson & Johnson and Boston Scientific when compared with older so-called bare metal stents.
The FDA said it was not yet clear if the drug stents carried an increased risk of heart attacks or death compared with the bare metal stents.
Key People or Organizations
70
FDA says drug stents have small blood clot risk Last Update: 11:15 AM ET May 5, 2008
WASHINGTON (MarketWatch) -- The Food and Drug Administration said Tuesday that drug-coated stents made by Johnson & Johnson (JNJ) and Boston Scientific Corp. (BSX) carry a significant risk of blood clots that appears to emerge a year or later after the stents are placed.
The agency said the risk applies to the drug stents currently on the U.S. market made by Johnson & Johnson and Boston Scientific when compared with older so-called bare metal stents.
The FDA said it was not yet clear if the drug stents carried an increased risk of heart attacks or death compared with the bare metal stents.
Establishing Associations Within Content
71
FDA says drug stents have small blood clot risk Last Update: 11:15 AM ET May 5, 2008
WASHINGTON (MarketWatch) -- The Food and Drug Administration said Tuesday that drug-coated stents made by Johnson & Johnson (JNJ) and Boston Scientific Corp. (BSX) carry a significant risk of blood clots that appears to emerge a year or later after the stents are placed.
The agency said the risk applies to the drug stents currently on the U.S. market made by Johnson & Johnson and Boston Scientific when compared with older so-called bare metal stents.
The FDA said it was not yet clear if the drug stents carried an increased risk of heart attacks or death compared with the bare metal stents.
Associating Content
72
SAN FRANCISCO (Thomson Financial) - St. Jude Medical Inc. said Wednesday the Food and Drug Administration has granted clearance for s Strada Carotid Guiding Sheath, a flexible tube that can be used to deliver balloon catheters, stents and other tools to open blockages in the carotid arteries.
The sheath also received European CE Mark approval, the St. Paul, Minn.-based medical device company said. The carotid arteries are vessels in the neck that supply blood to the brain,
face and scalp. Each year, an estimated 350,000 people in the United States undergo either surgery or a procedure in which a stent, a tiny company noted.
SAN FRANCISCO (Thomson Financial) - St. Jude Medical Inc. said Wednesday the Food and Drug Administration has granted clearance for its Strada Carotid Guiding Sheath, a flexible tube that can be used to deliver balloon catheters, stents and other tools to open blockages in the carotid arteries.
The sheath also received European CE Mark approval, the St. Paul, Minn.-based medical device company said. The carotid arteries are vessels in the neck that supply blood to the brain,
face and scalp. Each year, an estimated 350,00 people in the United States undergo either surgery or a procedure in which a stent, a tiny company noted.
St. Jude Medical: Guiding Sheath
receives FDA, CE Mark approvalLast Update: 11:15 AM ET May 5, 2008
SAN FRANCISCO (Thomson Financial) - St. Jude Medical Inc. said Wednesday the Food and Drug Administration has granted clearance for its Strada Carotid Guiding Sheath, a flexible tube that can be used to deliver balloon catheters, stents and other tools to open blockages in the carotid arteries.
The sheath also received European CE Mark approval, the St. Paul, Minn.-based medical device company said. The carotid arteries are vessels in the neck that supply blood to the brain, face and scalp. Each year, an estimated 350,000 people in the United States undergo either surgery or a procedure in which a stent, a tiny mesh tube, is inserted to restore blood flow through the carotid arteries, the company noted.
FDA says drug stents have small
blood clot risk Last Update: 11:15 AM ET May 5, 2008
WASHINGTON (MarketWatch) -- The Food and Drug Administration said Tuesday that drug-coated stents made by Johnson & Johnson (JNJ) and Boston Scientific Corp. (BSX) carry a small but significant risk of blood clots that appears to emerge a year or later after the stents are placed.
The agency said the risk applies to the two drug stents currently on the U.S. market made by Johnson & Johnson and Boston Scientific when compared with older so-called bare metal stents.
The FDA said it was not yet clear if the drug stents carried an increased risk of heart attacks or death compared with the bare metal stents.
Immersive: Avatar
New Online Immersive Technologies at G20
Avatars: Awareness
Virtual Conferences in 3D
What does this mean for the Enterprise?
The Internet is changing and morphing. It is NOT constant. Treat each era of the Internet differently.
The competitiveness of your organization will depend on your ability to use information technology wisely as an investment.
Your organization must be proficient in your primary mission but your competitive advantage will be driven by the innovative use of information.
To remain competitive your organization must use information more effectively than your rivals.
Thank You
78
